Myeloperoxidase Promoter Region Polymorphism and Lung Cancer Risk
Globally, lung cancer is the leading cause of cancer death accounting for nearly one million deaths each year (1 ). In the United States, lung cancer accounts for approx 13% of all incident cases and 28% of all cancer deaths (2 ). It has been estimated that 90% of male lung cancer deaths and over 75% of female lung cancer deaths in the U.S. are caused by cigarette smoking (3 ,4 ). Thus, elucidating the mechanisms of tobacco-induced lung cancer could lead to new strategies for decreasing lung cancer risk, for identifying susceptible individuals, and for developing innovative techniques for early detection (4 ). One such mechanism that has been intensively investigated is the structure, function, and end-point effects of genetic polymorphisms in human metabolic genes.
- MRD Detection in Acute Lymphoblastic Leukemia Patients Using Ig/TCR Gene Rearrangements as Targets for Real-Time Quantitative PC
- Expression Analysis of Homeobox Genes in Leukemia/Lymphoma Cell Lines
- Developing Anti-HER2/neu Single-Chain Fv Fragments from Phage Display Libraries
- Identification of Anaplastic Lymphoma Kinase Variant Translocations Using 5RACE
- Construction and Characterization of RNase-Based Targeted Therapeutics
- The Use of Fluorescent Probes in the Study of Reactive Oxygen Species in Pancreatic Cancer Cells
- Statistical Methods in Cancer Epidemiological Studies
- Quantitative Analysis of PRAME for Detection of Minimal Residual Disease in Leukemia
- Tumor-Specific Metastasis to Lung Using Reporter Gene-Tagged Tumor Cells
- Multicolor Spectral Karyotyping in Multiple Myeloma